ProQR Therapeutics N.V. at the annual general meeting of shareholders on June 30, 2022, approved the appointment of Management Board member Rene Beukema.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.82 USD | -8.54% | -3.08% | -4.55% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.55% | 16Cr | |
+19.07% | 13TCr | |
+14.53% | 11TCr | |
-4.83% | 2.46TCr | |
+3.23% | 2.28TCr | |
-10.44% | 1.82TCr | |
-41.74% | 1.65TCr | |
-13.31% | 1.65TCr | |
+2.72% | 1.34TCr | |
+28.86% | 1.11TCr |
- Stock Market
- Equities
- PRQR Stock
- News ProQR Therapeutics N.V.
- ProQR Therapeutics N.V. Appoints Rene Beukema as Member of Management Board